Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
236,833,431
-
Total 13F shares
-
97,211,593
-
Share change
-
+49,286,467
-
Total reported value
-
$137,058,638
-
Put/Call ratio
-
427%
-
Price per share
-
$1.41
-
Number of holders
-
79
-
Value change
-
+$69,617,810
-
Number of buys
-
47
-
Number of sells
-
29
Institutional Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q4 2021
As of 31 Dec 2021,
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
97,211,593 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Nuveen Asset Management, LLC, Stonepine Capital Management, LLC, VANGUARD GROUP INC, BOOTHBAY FUND MANAGEMENT, LLC, Magnetar Financial LLC, Clearline Capital LP, Velan Capital Investment Management LP, AWM Investment Company, Inc., and BlackRock Inc..
This page lists
79
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.